Americord collects, processes, and storages newborns' cord blood for future medical or therapeutic use. In addition to cord blood banking, we will also offer a proprietary process, called CordAdvantage (available later this year), which harvests stem cells from the placenta in addition to the umbilical cord blood. CordAdvantage may save many times more stem cells than cord blood banking alone. Americord is registered with the FDA and the company's laboratory is accredited by the AABB.